FDA conducts inspection of Dillon Companies, LLC in Denver on Sept. 11, 2024

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA
0Comments

The Food and Drug Administration carried out an inspection of Dillon Companies, LLC in Denver on September 11, 2024, according to data posted on the FDA’s website.

The FDA’s final report recommended that Dillon Companies, LLC address issues related to managing operations concerning foodborne biological hazards. No corrective actions were deemed necessary for other inspected areas.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Kyle Diamantas, J.D., Deputy Commissioner for Human Foods of FDA

FDA cites Coda Coffee Company for 2 violations in Denver inspection May 8

The Food and Drug Administration inspected Coda Coffee Company in Denver on May 8 for food composition, standards, labeling, economic issues and foodborne biological hazards, issuing two citations, according to the agency’s online records.

Benjamin D. Moncarz Chief Financial Officer - FDA

FDA conducts May 8 inspection of Coda Coffee Company in Denver

On May 8, the FDA inspected Coda Coffee Company in Denver, reviewing food composition, standards, labeling, economics, and foodborne biological hazards, according to information available on the FDA’s website.

Dr. Mehmet Oz CMS Administrator

Medicaid payments for Vision Services reach $7,712,077 in Denver for 2024

Denver saw a 5.2% rise in Medicaid payments for Vision Services in 2024, signaling shifts in utilization and reimbursement trends across the city.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Denver City Wire.